FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Jun. 30, 2023

Fair Value Disclosures [Abstract]

SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

					Fair Value Measurements
	As of June 30, 2023				As of June 30, 2023
	Amount		Fair Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen (1)	$	774	$	774	$	-	$	-	$	774
Note payable:
BroadOak loan		10,000		11,307		-		-		11,307
	$	10,774	$	12,081	$	-	$	-	$	12,081

(1) See Note 10, Other Accrued Expenses

					Fair Value Measurements
	As of December 31, 2022				As of December 31, 2022
	Amount		Fair Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen (1)	$	1,088	$	1,088	$	-	$	-	$	1,088
Note payable:
BroadOak loan		10,000		11,165		-		-		11,165
	$	11,088	$	12,253	$	-	$	-	$	12,253

(1) See Note 10, Other Accrued Expenses

SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability and BroadOak Loan to June 30, 2023 is as follows:

					Transferred			Accretion/		Adjustment to Fair Value/
	December				to Accrued			Interest		Mark to		June 30,
	31, 2022		Issued		Expenses			Accrued		Market		2023
Asuragen	$	1,088	$	-	$	(380	)	$	66	$	-	$	774
BroadOak loans		11,165		-		-			-		142		11,307
	$	12,253	$	-	$	(380	)	$	66	$	142	$	12,081